In vivo detection of experimental optic neuritis by pupillometry

Experimental Eye Research

Volumn 100, Issue , 2012, Pages 1-6

  Shindler, Kenneth S ^a   Revere, Karen ^a   Dutt, Mahasweta ^a   Ying, Gui Shuang ^b   Chung, Daniel C ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

EAE; Multiple sclerosis; Optic neuropathy; Pupillometry

Indexed keywords

MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MYELIN PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE COURSE; FEMALE; HISTOLOGY; IMMUNIZATION; IN VIVO STUDY; INCIDENCE; LIGHT; LIGHT INTENSITY; MOUSE; NONHUMAN; OPTIC NEURITIS; PRIORITY JOURNAL; PUPIL REFLEX; PUPILLOMETER; PUPILLOMETRY; VISION; ANIMAL; C57BL MOUSE; DISEASE MODEL; OPTIC NERVE; PATHOLOGY; PUPIL; RADIATION EXPOSURE;

ANIMALS; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; LIGHT; MICE; MICE, INBRED C57BL; MYELIN PROTEINS; OPTIC NERVE; OPTIC NEURITIS; PUPIL; REFLEX, PUPILLARY;

EID: 84862667124     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2012.04.005     Document Type: Article

References (24)

1. Arnold A.C. Evolving management of optic neuritis and multiple sclerosis. Am. J. Ophthalmol. 2005, 139:1101-1108.
2. Beck R.W., Cleary P.A., Anderson M.M., Keltner J.L., Shults W.T., Kaufman D.I., Buckley E.G., Corbett J.J., Kupersmith M.J., Miller N.R., et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. New Eng. J. Med. 1992, 326:581-588.
3. Dutt M., Tabuena P., Ventura E., Rostami A.M., Shindler K.S. Timing of corticosteroid therapy is critical to prevent retinal ganglion cell loss in experimental optic neuritis. Invest. Ophthalmol. Vis. Sci. 2010, 51:1439-1445.
4. Ellis C.J. The afferent pupillary defect in acute optic neuritis. J. Neurol. Neurosurg. Psychiat. 1979, 42:1008-1017.
5. Guy J., Qi X., Hauswirth W.W. Adeno-associated viral-mediated catalase expression suppresses optic neuritis in experimental allergic encephalomyelitis. Proc. Natl. Acad. Sci. 1998, 95:13847-13852.
6. Hobom M., Storch M.K., Weissert R., Maier K., Radhakrishnan A., Kramer B., Bähr M., Diem R. Mechanisms and time course of neuronal degeneration in experimental autoimmune encephalomyelitis. Brain Pathol. 2004, 14:148-157.
7. Hussain R.Z., Hopkins S.C., Frohman E.M., Eagar T.N., Cravens P.C., Greenberg B.M., Vernino S., Stüve O. Direct and consensual murine pupillary reflex metrics: establishing normative values. Auton. Neurosci. 2009, 151:164-167.
8. Liang K.Y., Zeger S.L. Longitudinal data analysis using generalized linear models. Biometrika 1986, 73:13-22.
9. Manno F.A.M. Pupillometry in mice: sex and strain-dependent phenotypes of pupillary functioning. Optom. Vis. Sci. 2009, 86:895-899.
10. Meyer R., Weissert R., Diem R., Storch M.K., de Graaf K.L., Kramer B., Bahr M. Acute neuronal apoptosis in a rat model of multiple sclerosis. J. Neurosci. 2001, 21:6214-6220.
11. Noseworthy J.H., Lucchinetti C., Rodriguez M., Weinshenker B.G. Multiple sclerosis. New Eng. J. Med. 2000, 343:938-952.
12. Optic Neuritis Study Group Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. Arch. Neurol. 2008, 65:727-732.
13. Potter N.T., Bigazzi P.E. Acute optic neuritis associated with immunization with the CNS myelin proteolipid protein. Invest. Ophthalmol. Vis. Sci. 1992, 33:1717-1722.
14. Quinn T., Dutt M., Shindler K.S. Optic neuritis and retinal ganglion cell loss in a chronic murine model of multiple sclerosis. Front. Neurol. 2011, 2:50.
15. Salter A.R., Conger A., Frohman T.C., Zivadinov R., Eggenberger E., Calabresi P., Cutter G., Balcer L., Frohman E.M. Retinal architecture predicts pupillary reflex metrics in MS. Mult. Scler. 2009, 15:479-486.
16. Santos A.M., Martin-Oliva D., Ferrer-Martin R.M., Tassi M., Calvente R., Sierra A., Carrasco M.C., Marín-Teva J.L., Navascués J., Cuadros M.A. Microglial response to light-induced photoreceptor degeneration in the mouse retina. J. Comp. Neurol. 2010, 518:477-492.
17. Shao H., Huang Z., Sun S.L., Kaplan H.J., Sun D. Myelin/oligodendrocyte glycoprotein-specific T-cells induce severe optic neuritis in the C57BL/6 mouse. Invest. Ophthalmol. Vis. Sci. 2004, 45:4060-4065.
18. Shindler K.S., Guan Y., Ventura E., Bennett J., Rostami A. Retinal ganglion cell loss induced by acute optic neuritis in a relapsing model of multiple sclerosis. Mult. Scler. 2006, 12:526-532.
19. Shindler K.S., Ventura E., Dutt M., Rostami A.M. Inflammatory demyelination induces axonal injury and retinal ganglion cell apoptosis in experimental optic neuritis. Exp. Eye Res. 2008, 87:208-213.
20. Shindler K.S., Ventura E., Rex T.S., Elliott P., Rostami A. SIRT1 activation confers neuroprotection in experimental optic neuritis. Invest. Ophthalmol. Vis. Sci. 2007, 48:3602-3609.
21. Surakka J., Ruutiainen J., Romberg A., Puukka P., Kronholm E., Karanko H. Pupillary function in early multiple sclerosis. Clin. Auton. Res. 2008, 18:150-154.
22. Wenzel A., Grimm C., Samardzija M., Reme C.E. Molecular mechanisms of light-induced photoreceptor apoptosis and neuroprotection for retinal degeneration. Prog. Retin. Eye Res. 2005, 24:275-306.
23. Xue T., Do M.T., Riccio A., Jiang Z., Hsieh J., Wang H.C., Merbs S.L., Welsbie D.S., Yoshioka T., Weissgerber P., Stolz S., Flockerzi V., Freichel M., Simon M.I., Clapham D.E., Yau K.W. Melanopsin signalling in mammalian iris and retina. Nature 2011, 479:67-73.
24. Zhu Y., Tu D.C., Denner D., Shane T., Fitzgerald C.M., Van Gelder R.N. Melanopsin-dependent persistence and photopotentiation of murine pupillary light responses. Invest. Ophthalmol. Vis. Sci. 2007, 48:1268-1275.